<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: Associations between <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> and its individual components with risk of incident <z:hpo ids='HP_0000726'>dementia</z:hpo> and its different subtypes are inconsistent </plain></SENT>
<SENT sid="1" pm="."><plain>RESEARCH DESIGN AND METHODS: The 7,087 community-dwelling subjects aged &gt; or =65 years were recruited from the French Three-City (3C) cohort </plain></SENT>
<SENT sid="2" pm="."><plain>Hazard ratios (over 4 years) of incident <z:hpo ids='HP_0000726'>dementia</z:hpo> and its subtypes (vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> and <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e>) and association with <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> (defined according to the National Cholesterol Education Program Adult Treatment Panel III criteria) and its individual components (<z:hpo ids='HP_0000822'>hypertension</z:hpo>, large waist circumference, high <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:hpo ids='HP_0003233'>low HDL cholesterol</z:hpo>, and elevated fasting glycemia) were estimated in separate Cox proportional hazard models </plain></SENT>
<SENT sid="3" pm="."><plain>RESULTS: <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">Metabolic syndrome</z:e> was present in 15.8% of the study participants </plain></SENT>
<SENT sid="4" pm="."><plain>The presence of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> increased the risk of incident vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> but not <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> over 4 years, independent of sociodemographic characteristics and the <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> (apo) Eepsilon4 allele </plain></SENT>
<SENT sid="5" pm="."><plain>High <z:chebi fb="0" ids="17855">triglyceride</z:chebi> level was the only component of <z:e sem="disease" ids="C0948265" disease_type="Disease or Syndrome" abbrv="">metabolic syndrome</z:e> that was significantly associated with the incidence of <z:hpo ids='HP_0000001'>all</z:hpo>-cause (hazard ratio 1.45 [95% CI 1.05-2.00]; P = 0.02) and vascular (2.27 [1.16-4.42]; P = 0.02) <z:hpo ids='HP_0000726'>dementia</z:hpo>, even after adjustment of the apoE genotype </plain></SENT>
<SENT sid="6" pm="."><plain><z:mp ids='MP_0002055'>Diabetes</z:mp>, but not impaired fasting glycemia, was significantly associated with <z:hpo ids='HP_0000001'>all</z:hpo>-cause (1.58 [1.05-2.38]; P = 0.03) and vascular (2.53 [1.15-5.66]; P = 0.03) <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSIONS: The observed relation between high <z:chebi fb="4" ids="17855">triglycerides</z:chebi>, <z:mp ids='MP_0002055'>diabetes</z:mp>, and vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> emphasizes the need for detection and treatment of vascular risk factors in older individuals in order to prevent the likelihood of clinical <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
</text></document>